Ratajczak, P.; Banach, Z.; Kopciuch, D.; Paczkowska, A.; Zaprutko, T.; Krawczyk, J.; Maciuszek-Bartkowska, B.; Kus, K.
Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19—A Systematic Review of Randomised Controlled Trial Studies. Healthcare 2023, 11, 1532.
https://doi.org/10.3390/healthcare11111532
AMA Style
Ratajczak P, Banach Z, Kopciuch D, Paczkowska A, Zaprutko T, Krawczyk J, Maciuszek-Bartkowska B, Kus K.
Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19—A Systematic Review of Randomised Controlled Trial Studies. Healthcare. 2023; 11(11):1532.
https://doi.org/10.3390/healthcare11111532
Chicago/Turabian Style
Ratajczak, Piotr, Zuzanna Banach, Dorota Kopciuch, Anna Paczkowska, Tomasz Zaprutko, Józef Krawczyk, Barbara Maciuszek-Bartkowska, and Krzysztof Kus.
2023. "Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19—A Systematic Review of Randomised Controlled Trial Studies" Healthcare 11, no. 11: 1532.
https://doi.org/10.3390/healthcare11111532
APA Style
Ratajczak, P., Banach, Z., Kopciuch, D., Paczkowska, A., Zaprutko, T., Krawczyk, J., Maciuszek-Bartkowska, B., & Kus, K.
(2023). Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19—A Systematic Review of Randomised Controlled Trial Studies. Healthcare, 11(11), 1532.
https://doi.org/10.3390/healthcare11111532